SIMCERE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SIMCERE Trademark

Serial Number: 79276391 • Registration: 6202775

SIMCERE is a trademark filed by Jiangsu Simcere Pharmaceutical Co., Ltd on September 2, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jiangsu Simcere Pharmaceutical Co., Ltd (6 trademarks)

No.699-18, Xuanwu Avenue,

Entity Type: 03

Trademark Details

Filing Date

September 2, 2019

Registration Date

November 24, 2020

Published for Opposition

September 8, 2020

Goods & Services

Medicated troches; Medicines for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes; [ Biochemicial ] * Biochemical * drug for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musculo-skeletal disorders, infections, and bacterial infections, all for human purposes; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Active pharmaceutical ingredients, namely, extracts of hops for pharmaceutical purposes, eucalyptus for pharmaceutical purposes, mint for pharmaceutical purposes, malt for pharmaceutical purposes, pepsins for pharmaceutical purposes,thymol for pharmaceutical purposes,turpentine for pharmaceutical purposes, flaxseed for pharmaceutical purposes, ferments for pharmaceutical purposes, cytostatics for pharmaceutical purposes, balms for pharmaceutical purposes, digestives for pharmaceutical purposes, iodine for pharmaceutical purposes, alcohol for pharmaceutical purposes, starch for pharmaceutical purposes; Pharmaceutical preparations for injection for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes; Chinese patent medicines for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, and, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 24, 2025 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 18, 2024 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 8, 2024 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Sep 12, 2023 NURC
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 16, 2023 CORR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 8, 2023 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Aug 8, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 8, 2023 APRE
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 9, 2023 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Oct 27, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 3, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 3, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 3, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 3, 2020 CNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 27, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 27, 2020 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 23, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 13, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 27, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 21, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 16, 2020 REPR